Latest Asset Impairment News

Insignia Financial Group reported a strong half-year with revenue up 7.8% and profit after tax surging 569%, despite a significant impairment on an associate investment and no dividends declared.

IGO Limited reports a marked improvement in its half-year results, narrowing losses and boosting cash flow amid operational challenges and strategic asset sales.

MGX Resources reported a $20.8 million half-year loss, driven by a major rockfall at Koolan Island that halted mining and triggered a $60 million asset impairment. The company is pivoting towards gold with its recent acquisition of a 50% stake in the Central Tanami Project.

SkyCity Entertainment Group posted a solid half-year profit increase to NZD 12.1 million despite a slight revenue dip, bolstered by a major equity raise and a clean bill on its Adelaide casino licence.

Iluka Resources posted a net loss of $288 million in 2025 amid subdued mineral sands demand but progressed key projects including the Balranald mine commissioning and Eneabba rare earths refinery construction.

Clever Culture Systems posted a $1.32 million loss for the half year ending December 2025, reflecting a strategic shift and reduced government grants. Despite this, the company strengthened its cash position, repaid government debt, and grew its APAS Independence instrument footprint globally.

Treasury Wine Estates reported a statutory loss driven by a significant US asset impairment but showed underlying growth in key markets. The company suspends its interim dividend and targets $100 million in annual cost savings through its TWE Ascent program.

Treasury Wine Estates reports a sharp 39.6% drop in earnings and a $649 million statutory loss due to a major US asset impairment, suspending dividends to preserve capital while advancing a $100 million cost-cutting transformation.

Treasury Wine Estates has reported a staggering $649.4 million net loss for the half year ending December 2025, driven by significant impairments on US assets and a drop in revenue. The company has suspended its interim dividend and unveiled a new Luxury-led operating model as it navigates these challenges.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.

Rapid Critical Metals has completed the acquisition of the Webbs Consol Silver Project and discovered a new parallel silver lode at its Webbs Silver Project, positioning the company for significant growth in 2026.

James Hardie Industries is set to close its Fontana and Summerville manufacturing plants, consolidating production to boost efficiency and cut costs by $25 million annually starting next fiscal year.